UAMY - Beautiful Setup with Key Changes in ManagementNew CEO is Mr. Evans Evans has served for 24 years as a Director of Novavax Inc., a NASDAQ listed (“NVAX”) clinical-stage vaccine biotechnology company (Covid-19 Vaccine) with a market capitalization in excess of $15 Billion, and previously served as Chairman, CEO and Lead Director.
Gary Evans has